ePrints

The effect of NAT2 genotype and gender on the metabolism of caffeine in nonsmoking subjects

Lookup NU author(s): Dr Mark Welfare, Professor Margaret Bassendine, Professor Ann DalyORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Aims. To establish whether gender or N-acetyltransferase 2 (NAT2) genotype influence the urinary 17 U + 17X/137X ratio after dosing with caffeine. Methods. Ninety-two nonsmoking individuals underwent caffeine phenotyping. NAT2 genotype was determined by the polymerase chain reaction followed by a restriction digest (PCR-RFLP). Results. The median ratio for urinary 17 U + 17X/137X was 6.7 (range 1.45-18.65). 55% of subjects were slow acetylators. Gender did not affect the metabolic ratio or NAT2 genotype. Mean 17 U + 17X/137X ratio differed between fast (6.75) and slow (8.69) acetylators (95% CI for the difference, 0.32-3.56). Conclusions. The findings are further evidence that the 17 U + 17X/137X urinary ratio is not a robust measure of CYP1A2 activity. A possible mechanism by which the ratio might be influenced by NAT2 genotype is suggested.

Publication metadata

Author(s): Daly AK; Bassendine MF; Welfare MR

Publication type: Article

Publication status: Published

Journal: British Journal of Clinical Pharmacology

Year: 2000

Volume: 49

Issue: 3

Pages: 240-243

ISSN (print): 0306-5251

ISSN (electronic): 1365-2125

Publisher: Wiley-Blackwell Publishing Ltd.

URL: http://dx.doi.org/10.1046/j.1365-2125.2000.00130.x

DOI: 10.1046/j.1365-2125.2000.00130.x

PubMed id: 10718779

Altmetrics

Share